Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
198.15
+5.12 (2.65%)
At close: Dec 15, 2025, 4:00 PM EST
198.01
-0.14 (-0.07%)
After-hours: Dec 15, 2025, 7:26 PM EST
CRL Stock Forecast
Stock Price Forecast
The 12 analysts that cover CRL stock have a consensus rating of "Buy" and an average price target of $191, which forecasts a -3.61% decrease in the stock price over the next year. The lowest target is $170 and the highest is $215.
Price Target: $191 (-3.61%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 3 | 4 | 4 |
| Hold | 10 | 10 | 10 | 9 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 15 | 16 | 15 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $210 → $215 | Buy | Maintains | $210 → $215 | +8.50% | Dec 15, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $165 → $190 | Hold | Maintains | $165 → $190 | -4.11% | Dec 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $170 → $185 | Hold | Maintains | $170 → $185 | -6.64% | Nov 11, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $205 → $197 | Strong Buy | Maintains | $205 → $197 | -0.58% | Nov 10, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $160 → $165 | Hold | Maintains | $160 → $165 | -16.73% | Nov 6, 2025 |
Financial Forecast
Revenue This Year
4.05B
from 4.05B
Decreased by -0.05%
Revenue Next Year
4.12B
from 4.05B
Increased by 1.66%
EPS This Year
10.34
from 0.20
Increased by 5,068.27%
EPS Next Year
10.97
from 10.34
Increased by 6.14%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.2B | 4.4B | ||||
| Avg | 4.0B | 4.1B | ||||
| Low | 3.9B | 4.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.5% | 7.8% | ||||
| Avg | -0.0% | 1.7% | ||||
| Low | -4.6% | -2.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.86 | 12.98 | |||
| Avg | 10.34 | 10.97 | |||
| Low | 9.95 | 9.61 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5,328.5% | 25.5% | |||
| Avg | 5,068.3% | 6.1% | |||
| Low | 4,875.5% | -7.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.